STMicroelectronics (NYSE:STM) was in the spotlight on Monday as investment firm TD Cowen downgraded the industrial-focused ...

TD Cowen downgraded STMicroelectronics (STM) to Hold from Buy with a price target of $25, down from $32. The firm says broad-based ...

In a report released today, Max Rakhlenko from TD Cowen maintained a Hold rating on Tractor Supply (TSCO – Research Report), with a price ...

On Monday, Jan. 7, Michael Lavery at Piper Sandler initiated coverage of the beverage giant, with an overweight rating and a ...

Fintel reports that on January 8, 2025, TD Cowen downgraded their outlook for WK Kellogg (NYSE:KLG) from Hold to Sell.

The cost of prescription drugs is set to climb in 2025 and beyond, according to TD Cowen’s 30th Annual Drug Pricing survey.

The S&P 500 gained 0.55% to close at 5,975.38. The Nasdaq Composite advanced 1.24% to end at 19,864.98. The Dow Jones ...

Lisa Thomas, Managing Director and Deputy Head of Global Research at TD Cowen, discusses some of the key findings of a new TD Cowen report on the big investment themes of 2025, including shifting ...

El Lilly’s blockbuster weight-loss drug Zepbound is now eligible for coverage under Medicare prescription drug plans, when ...

Shares of American Airlines surged Monday after brokerages Jefferies and TD Cowen upgraded and raised their price targets on ...

TD Cowen analyst Jeff Osborne initiated coverage of Nextracker (NXT) with a Hold rating and $41 price target The firm likes the company’s management team, portfolio and market presence and sees ...

TD Cowen initiated coverage of Waldencast (WALD) with a Hold rating and $4.30 price target The firm says that while Obagi and Milk have unique positioning in the beauty space with opportunities to ...